statistiche ricercatore

SPANEVELLO, ANTONIO

Distribuzione geografica

Continente	#
NA - Nord America	22.243
EU - Europa	10.527
AS - Asia	8.321
SA - Sud America	1.028
AF - Africa	210
OC - Oceania	47
Continente sconosciuto - Info sul continente non disponibili	12
Totale	42.388

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	21.992
IT - Italia	5.162
SG - Singapore	2.711
CN - Cina	2.097
UA - Ucraina	1.554
VN - Vietnam	1.088
HK - Hong Kong	976
BR - Brasile	849
TR - Turchia	689
SE - Svezia	649
GB - Regno Unito	575
IE - Irlanda	550
DE - Germania	465
FI - Finlandia	460
FR - Francia	386
RU - Federazione Russa	302
BD - Bangladesh	264
IN - India	118
NL - Olanda	113
MX - Messico	111
CA - Canada	110
NG - Nigeria	100
AT - Austria	74
JP - Giappone	68
AR - Argentina	66
IQ - Iraq	41
PL - Polonia	39
AU - Australia	34
ZA - Sudafrica	30
ID - Indonesia	29
BE - Belgio	28
ES - Italia	28
SA - Arabia Saudita	28
EC - Ecuador	27
PK - Pakistan	27
CZ - Repubblica Ceca	23
KR - Corea	23
MA - Marocco	22
CL - Cile	18
VE - Venezuela	18
CH - Svizzera	17
MY - Malesia	17
UZ - Uzbekistan	17
CO - Colombia	15
PE - Perù	14
TW - Taiwan	14
AE - Emirati Arabi Uniti	12
NZ - Nuova Zelanda	12
DZ - Algeria	11
EU - Europa	11
HU - Ungheria	11
KZ - Kazakistan	11
MD - Moldavia	11
NP - Nepal	11
RO - Romania	11
JO - Giordania	10
LT - Lituania	10
KE - Kenya	9
PY - Paraguay	9
AL - Albania	8
AZ - Azerbaigian	8
CR - Costa Rica	8
EG - Egitto	8
PH - Filippine	8
SK - Slovacchia (Repubblica Slovacca)	8
TH - Thailandia	8
TN - Tunisia	8
BO - Bolivia	7
IR - Iran	7
NO - Norvegia	7
OM - Oman	7
PT - Portogallo	7
GR - Grecia	6
DK - Danimarca	5
HN - Honduras	5
SN - Senegal	5
TT - Trinidad e Tobago	5
BG - Bulgaria	4
BH - Bahrain	4
CI - Costa d'Avorio	4
LK - Sri Lanka	4
UY - Uruguay	4
BA - Bosnia-Erzegovina	3
BY - Bielorussia	3
IL - Israele	3
KH - Cambogia	3
LB - Libano	3
LY - Libia	3
MM - Myanmar	3
PA - Panama	3
BB - Barbados	2
GD - Grenada	2
GE - Georgia	2
GN - Guinea	2
HR - Croazia	2
LU - Lussemburgo	2
RS - Serbia	2
SY - Repubblica araba siriana	2
ZM - Zambia	2
BN - Brunei Darussalam	1
Totale	42.365

Salva come PNG Salva come JPEG

Città	#
Milan	3.455
Fairfield	2.338
Woodbridge	1.831
Ashburn	1.786
San Jose	1.654
Singapore	1.450
Jacksonville	1.259
Houston	1.213
Ann Arbor	1.207
Chandler	1.100
Hong Kong	962
Seattle	929
Wilmington	929
Cambridge	788
Dallas	561
Dublin	533
Princeton	532
Shenzhen	466
Dearborn	410
Council Bluffs	400
Boardman	380
The Dalles	380
Izmir	372
Nyköping	314
Chicago	307
Beijing	305
Rome	290
Dong Ket	285
Lauterbourg	284
New York	220
Ho Chi Minh City	185
San Diego	171
London	152
Los Angeles	138
Hanoi	134
Como	126
Helsinki	123
San Mateo	120
Santa Clara	115
Ogden	104
Abuja	95
São Paulo	88
Hefei	77
Mexico City	74
Munich	70
Guangzhou	69
Washington	67
Falls Church	57
Tokyo	57
Kocaeli	49
Shanghai	47
Orem	46
Nanjing	44
Nuremberg	43
Columbus	41
Frankfurt am Main	41
San Francisco	41
Vienna	41
Phoenix	40
Kunming	39
Toronto	39
Amsterdam	38
Salt Lake City	38
Atlanta	36
Norwalk	36
Brooklyn	34
Chennai	34
Rio de Janeiro	32
San Genesio Ed Uniti	32
Warsaw	31
Verona	30
Tianjin	29
Buffalo	28
Hangzhou	27
Jinan	26
Montreal	25
Brussels	24
Tampa	24
Zhengzhou	24
Düsseldorf	23
Redmond	23
Philadelphia	22
Redwood City	22
Da Nang	21
Haiphong	21
Naples	20
Belo Horizonte	19
Stockholm	19
Magnago	18
Pavia	18
Elk Grove Village	17
Johannesburg	17
Kilburn	17
Manchester	17
Shenyang	17
Baghdad	16
Brno	16
Dhaka	16
Nanchang	16
Ankara	15
Totale	30.411

Salva come PNG Salva come JPEG

Nome	#
Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis	591
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	330
Airway inflammation in patients affected by obstructive sleep apnea	297
The effects of a cognitive behavioural intervention in asthmatic patients.	297
Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery	255
Classifying new anti-tuberculosis drugs: rationale and future perspectives	249
Six-Minute Walking Distance Improvement after Pulmonary Rehabilitation Is Associated with Baseline Lung Function in Complex COPD Patients: A Retrospective Study	241
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis	232
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	231
Aging and airway inflammation	230
A European Respiratory Society technical standard: exhaled biomarkers in lung disease	230
Aging and induced-sputum cells	218
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.	217
A new Editorial Board of Monaldi Archives for Chest Disease	214
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases	213
Models of respiratory infections: Virus-induced asthma exacerbations and beyond	213
Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome	212
A pilot study of nurse-led, home monitoring for patients with chronic respiratory failure and with mechanical ventilation assistance	212
Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy	212
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	212
Clinical and operational value of the extensively drug-resistant tuberculosis definition	210
Therapeutic drug monitoring: How to improve drug dosage and patient safety in tuberculosis treatment	210
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients.	208
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation	206
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis	201
Bronchoalveolar lavage causes decrease in PaO2, increase in (A-a) gradient value and bronchoconstriction in asthmatics	200
Menopausal asthma: a new biological phenotype?	200
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial	200
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB	199
Brittle Asthma	198
When kidneys and lungs suffer together	198
Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey	197
Ripped from the headlines: how can we harness communications to control TB?	196
Tuberculosis elimination: theory and practice in Europe	196
Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects	196
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study	195
Improving the TB case management: The International Standards for Tuberculosis Care	195
Induced sputum to assess airway inflammation: a study of reproducibility	195
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate	195
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results	194
History of tuberculosis and drug resistance	193
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	192
Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma	192
Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.	191
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials	191
Markers of airway inflammation in pulmonary diseases assessed by induced sputum.	191
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation.	190
Economic analysis of two structured treatment and teaching programs on asthma	190
Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD	190
Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD	189
In vitro susceptibility testing and totally drug-resistant tuberculosis	189
Tele-assistance in Chronic Respiratory Failure Patients: a Randomised Clinical Trial.	188
AIDS and tuberculosis control programmes: an integrated approach at educational level.	188
Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance	188
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease	188
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8	187
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults	186
Sputum induced cellularity in a group of traffic policemen	186
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis	186
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD	185
European union standards for tuberculosis care	185
Effect of methacholine challenge on cellular composition of sputum induction	184
Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance.	184
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB	184
Airway inflammation in healthy smokers	183
Airway inflammation in patients affected by obstructive sleep apnea syndrome.	183
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution	183
Effects of intradermal injection of atrial natriuretic peptide.	182
Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity	181
Comparison of two methods of processing induced sputum: selected versus entire sputum	180
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?	179
An electronic nose in the discrimination of patients with asthma and controls	179
Heterogeneity of pulmonary rehabilitation: like apples and oranges - both healthy fruit	179
Latex allergy and sensitization in cities: a survey in a population at risk	179
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment	178
Tuberculosis elimination: Where are we now?	177
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells	175
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	175
Chronic bronchial asthma from challenge to treatment: epidemiology and social impact	174
Recent developments in the diagnosis and management of tuberculosis	174
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET	173
Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design	173
Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough	173
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma	172
Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy	172
SPUTUM AND EXHALED BREATH ANALYSIS	171
Development of a Barthel Index based on dyspnea for patients with respiratory diseases	171
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis	169
Assembly 5: Airway diseases	169
Is bronchodilator the correct treatment for COPD subjects before EBUS?	168
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease	168
Exhaled inflammatory markers in aspirin-induced asthma syndrome	168
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease	166
The new frontiers of rehabilitation medicine in people with chronic disabling illnesses	166
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease	164
The mechanics of the lung parenchyma and airway responsiveness to metacholine.	164
Computerized patient record for a department of respiratory rehabilitation.	164
Management of drug resistantTB in patients with HIV co-infection	164
Genotyping of microsatellite alterations and EGFR somatic mutations in exhaled breath condensate of NSCLC patients	162
MDR-TB and XDR-TB: drug resistance and treatment outcomes.	162
Totale	19.832

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	185.717
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	185.717

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	693	0	0	0	0	0	0	0	0	0	0	0	693
2021/2022	2.742	315	328	168	70	83	185	204	176	157	486	221	349
2022/2023	3.395	441	147	291	360	225	701	39	366	452	148	121	104
2023/2024	6.222	840	865	1.323	1.037	1.175	404	101	117	185	94	51	30
2024/2025	4.451	53	93	781	151	180	355	163	271	523	447	319	1.115
2025/2026	10.801	539	566	685	1.167	703	520	2.556	682	1.351	786	694	552
Totale													43.054